Fei Ding
Impact in
-
- Nerve injury and regeneration
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
-
- MicroRNA in disease regulation
Papers in
-
- MicroRNA in disease regulation 3
-
- Nerve injury and regeneration 2
- Co-authors
- Bin Yu (3 shared papers)Yongjun Wang (3 shared papers)Xiao-song Gu (4 shared papers)Songlin Zhou (2 shared papers)Guohui Ding (1 shared paper)Dingding Shen (1 shared paper)Xiaoyan Tang (1 shared paper)Leilei Gong (2 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)PLoS ONE (2 papers)Reproduction (1 paper)BMC Pulmonary Medicine (1 paper)Biomedical Chromatography (1 paper)
- Partner nations
- ChinaDenmarkUnited States
In The Last Decade
Fei Ding
19 papers receiving 395 citations
Peers
Comparison fields: 5 of 58
- Cellular and Molecular Neuroscience 144
- Cancer Research 64
- Developmental Neuroscience 10
- Neurology 12
- Biological Psychiatry 2
Countries citing papers authored by Fei Ding
This map shows the geographic impact of Fei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Ding more than expected).
Fields of papers citing papers by Fei Ding
This network shows the impact of papers produced by Fei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Ding. The network helps show where Fei Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 100 | |
| 2 | 2011 | 83 | |
| 3 | 2009 | 49 | |
| 4 | 2013 | 37 | |
| 5 | 2019 | 18 | |
| 6 | 2017 | 17 | |
| 7 | 2019 | 15 | |
| 8 | 2018 | 11 | |
| 9 | 2021 | 11 | |
| 10 | 2022 | 11 | |
| 11 | 2008 | 10 | |
| 12 | 2014 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 6 | |
| 15 | 2012 | 5 | |
| 16 | 2008 | 3 | |
| 17 | 2018 | 3 | |
| 18 | MiR-422a in gastric cancer cells directly targets CDC40 and modulates cell proliferation. | 2020 | 3 |
| 19 | 2024 | 2 | |
| 20 | 2025 | 0 |
About Fei Ding
Fei Ding is a scholar working on Cancer Research, Cellular and Molecular Neuroscience, Reproductive Medicine, Rheumatology and Neurology, having authored 21 papers that have together received 398 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Reproductive Biology and Fertility (2 papers), Nerve injury and regeneration (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Receptor Mechanisms and Signaling (1 paper), Analytical Methods in Pharmaceuticals (1 paper), Plant Molecular Biology Research (1 paper) and Lymphadenopathy Diagnosis and Analysis (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (144 citations), Cancer Research (64 citations), Developmental Neuroscience (10 citations), Neurology (12 citations) and Biological Psychiatry (2 citations). Fei Ding has collaborated with scholars based in China, Denmark and United States. Frequent co-authors include Bin Yu, Yongjun Wang, Xiao-song Gu, Songlin Zhou, Guohui Ding, Dingding Shen, Xiaoyan Tang, Leilei Gong, Defang Gan and Yang Zhao. Their work appears in journals such as Biochemical and Biophysical Research Communications, PLoS ONE, Reproduction, BMC Pulmonary Medicine and Biomedical Chromatography.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.